You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BioNTech RNA

Showing 1 - 25 of 1,486
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Kidney Transplant Recipients Trial in Baltimore (mRNA-1273 vaccine (Pfizer/BioNTech), mRNA-1273 vaccine (Moderna))

Active, not recruiting
  • Kidney Transplant Recipients
  • mRNA-1273 vaccine (Pfizer/BioNTech)
  • mRNA-1273 vaccine (Moderna)
  • Baltimore, Maryland
    Johns Hopkins Hospital
Oct 4, 2021

COVID-19, Corona Virus Infection Trial in Ann Arbor (Pfizer-BioNTech mRNA COVID-19 vaccine, Moderna mRNA COVID-19 vaccine)

Recruiting
  • COVID-19
  • Corona Virus Infection
  • Pfizer-BioNTech mRNA COVID-19 vaccine
  • Moderna mRNA COVID-19 vaccine
  • Ann Arbor, Michigan
    University of Michigan
Apr 23, 2022

Carcinoma, Squamous Cell, Head and Neck Tumor, Cervical Tumor Trial in Southampton (BNT113)

Recruiting
  • Carcinoma, Squamous Cell
  • +3 more
  • Southampton, Hampshire, United Kingdom
    Univeristy Hospitals Southampton NHS Foundation Trust
May 17, 2022

Metastatic Tumor Trial in Worldwide (SAR441000, Cemiplimab REGN2810)

Active, not recruiting
  • Metastatic Neoplasm
  • Fairway, Kansas
  • +20 more
Aug 11, 2022

Kidney Transplant Recipients, Liver Transplant Recipients Trial in United States (Pfizer-BioNTech COVID-19 Vaccine Booster,

Recruiting
  • Kidney Transplant Recipients
  • Liver Transplant Recipients
  • Pfizer-BioNTech Bivalent COVID-19 Vaccine
  • +3 more
  • San Diego, California
  • +14 more
Oct 31, 2022

Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Pemphigus Vulgaris Trial in United States (Moderna mRNA-1273,

Recruiting
  • Rheumatoid Arthritis
  • +8 more
  • Moderna mRNA-1273
  • +5 more
  • Los Angeles, California
  • +24 more
Aug 17, 2022

Melanoma Trial in Germany (Lipo-MERIT)

Active, not recruiting
  • Melanoma
  • Lipo-MERIT
  • Frankfurt, Germany
  • +3 more
Jan 5, 2023

COVID-19 Trial in Bandung (Pfizer-BioNTech Standard dose, AstraZeneca Standard dose, Pfizer-BioNTech Fractional dose)

Not yet recruiting
  • COVID-19
  • Pfizer-BioNTech Standard dose
  • +5 more
  • Bandung, West Java, Indonesia
  • +2 more
Nov 30, 2022

Chronic Kidney Diseases, COVID-19 Trial in Scarborough, Toronto (Pfizer-BioNTech COVID-19 Vaccine, MODERNA SARS-CoV-2 Vaccine)

Active, not recruiting
  • Chronic Kidney Diseases
  • COVID-19
  • Pfizer-BioNTech COVID-19 Vaccine
  • MODERNA SARS-CoV-2 Vaccine
  • Scarborough, Ontario, Canada
  • +2 more
Aug 5, 2022

COVID-19 Trial in Melbourne (Tozinameran - Standard dose, Tozinameran - fractional dose, Elasomeran - standard dose)

Active, not recruiting
  • COVID-19
  • Tozinameran - Standard dose
  • +3 more
  • Melbourne, Victoria, Australia
    Royal Children's Hospital
Aug 24, 2022

Malaria Trial (BNT165e, Placebo)

Not yet recruiting
  • Malaria
  • BNT165e
  • Placebo
  • (no location specified)
Sep 29, 2023

Monkeypox Trial (BNT166a, BNT166c)

Not yet recruiting
  • Monkeypox
  • BNT166a
  • BNT166c
  • (no location specified)
Aug 4, 2023

Malaria Trial in Tempe, Knoxville, San Antonio (BNT165b1, Placebo)

Recruiting
  • Malaria
  • BNT165b1
  • Placebo
  • Tempe, Arizona
  • +2 more
Jan 12, 2023

Tuberculosis Trial (BNT164a1, BNT614b1, Placebo)

Not yet recruiting
  • Tuberculosis
  • BNT164a1
  • +2 more
  • (no location specified)
Jan 18, 2023

Immunocompromised Patients Trial in Switzerland (Moderna COVID-19 Vaccine, mRNA-1273 (100 µg), Pfizer-BioNTech COVID-19 Vaccine

Active, not recruiting
  • Immunocompromised Patients
  • Moderna COVID-19 Vaccine, mRNA-1273 (100 μg)
  • Pfizer-BioNTech COVID-19 Vaccine BNT162b2 (30 µg)( Comirnaty®)
  • Basel, Switzerland
  • +3 more
Oct 18, 2022

Tuberculosis Trial (BNT164a1, BNT614b1, Placebo)

Not yet recruiting
  • Tuberculosis
  • BNT164a1
  • +2 more
  • (no location specified)
Sep 8, 2022

COVID-19 Trial in Bizerte, Ariana, Tunis (CoronaVac/CoronaVac, CoronaVac/BNT162b2)

Completed
  • COVID-19
  • CoronaVac/CoronaVac
  • CoronaVac/BNT162b2
  • Bizerte, Mateur, Tunisia
  • +4 more
Jan 4, 2023

SARS-CoV-2 Infection, COVID-19 Trial in United States (BNT162b2 (Omi XBB.1.5))

Not yet recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2 (Omi XBB.1.5)
  • Dublin, California
  • +14 more
Aug 10, 2023

Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients

Not yet recruiting
  • Covid-19 Pandemics
  • Tuberculosis
  • Pfizer-BioNTech COVID-19 vaccine
  • +2 more
  • Mae Sot, Tak, Thailand
    Shoklo Malaria Research Unit (SMRU)
Oct 21, 2022

Vaccine-generated Immunity in Ocrelizumab-treated Patients:

Active, not recruiting
  • Multiple Sclerosis
  • SARS-COV-2 mRNA Vaccine
  • Denver, Colorado
  • +1 more
Apr 4, 2022

COVID-19 Trial (Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose, Bivalent BNT162b2 (original/Omicron BA.4/BA.5)

Not yet recruiting
  • COVID-19
  • Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose
  • +3 more
  • (no location specified)
Dec 22, 2022

COVID-19 Trial in United States (Ad26.COV2.S, BNT162b2, mRNA-1273)

Recruiting
  • COVID-19
  • Ad26.COV2.S
  • +4 more
  • Atlanta, Georgia
  • +11 more
Aug 11, 2022

Chronic Liver Disease Trial in Hong Kong (BNT162b2, CoronaVac, AZD1222)

Recruiting
  • Chronic Liver Disease
  • BNT162b2
  • +2 more
  • Hong Kong, Hong Kong
    Humanity & Health Medical Group Limited
Aug 1, 2022

SARS-CoV2 Infection, Covid19, SARS-CoV-2 Acute Respiratory Disease Trial in Worldwide (BNT162b2, BNT162b2 (B.1.1.7 + B.1.617.2),

Active, not recruiting
  • SARS-CoV2 Infection
  • +3 more
  • BNT162b2
  • +5 more
  • Long Beach, California
  • +34 more
Jan 10, 2023

COVID-19 Trial in Melbourne (Tozinameran, Elasomeran, Bivalent Pfizer-BioNTech)

Not yet recruiting
  • COVID-19
  • Tozinameran
  • +3 more
  • Melbourne, Victoria, Australia
    Royal Children's Hospital, Murdoch Children's Research Institute
Sep 14, 2022